The 2024 WHO Bacterial Priority Pathogens List (WHO BPPL) is a vital resource for combating antimicrobial resistance (AMR), one of humanity’s greatest health and development threats. Indonesia is especially at risk of AMR and is among five countries globally with the highest projected percentage increase in antimicrobial consumption by 2030.
This updated publication provides essential guidance for policy makers, national health authorities and relevant stakeholders to prioritize research and development (R&D) and investments in addressing antibiotic-resistant pathogens. It categorizes 24 pathogens across 15 pathogen families, grouped into critical, high and medium categories of priority for R&D and public health measures.
As highlighted in the Global Antimicrobial Resistance and Use Surveillance report 2023, Indonesia has in recent years reported resistant strains of Acinetobacter baumanii, Escherichia coli and Klebsiella pneumoniae. The WHO BPPL can help Indonesia – as all countries globally – prevent and control the emergence and spread of these and other pathogens, ensuring our most precious drugs remain fit for purpose.